Form 4: VolitionRx COO Gaetan Michel Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Gaetan Michel, COO of VolitionRx, reports a transaction involving the withholding of shares to cover tax obligations upon the settlement of restricted stock units.
Summary
- On May 1, 2025, VolitionRx retained 6,844 shares of common stock from Gaetan Michel, the company's COO.
- This was done to cover tax withholding obligations related to the settlement of 13,689 restricted stock units awarded to Michel in lieu of cash compensation.
- The shares were withheld at a price of $0.4875 per share.
- Following the transaction, Michel directly owns 388,276 shares of VolitionRx common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine tax-related stock transaction, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of compliance for company insiders and provide transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/01/2025 | Date of the stock transaction (tax withholding). |
| 05/05/2025 | Date of signature on the Form 4 filing. |
Keywords
VolitionRx, Gaetan Michel, Form 4, Stock Transaction, Restricted Stock Units, Tax Withholding, VNRX, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.